MedPath
FDA Approval

Nilandron

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 8, 2022
Labeling Type
Human Prescription Drug Label
Nilutamide(150 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nilandron

Product Details

NDC Product Code
59212-111
Application Number
NDA020169
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
July 8, 2022
Code: 51G6I8B902Class: ACTIBQuantity: 150 mg in 1 1
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
LACTOSEInactive
Code: J2B2A4N98GClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath